Cargando…

Plasma amyloid β levels in Alzheimer’s disease and cognitively normal controls in Syrian population

Background: The pathogenesis of Alzheimer’s disease (AD) is believed to be occurred by the production of neurotic plaques of the beta-amyloid peptide (Aβ) and deposition of them. Therefore, biomarkers of abnormal Aβ processing may represent before the AD clinical biomarkers, which could be benefit f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manafikhi, Rafah, Haik, M. Bassam, Lahdo, Raghda, AlQuobaili, Faizeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111637/ https://www.ncbi.nlm.nih.gov/pubmed/33996670 http://dx.doi.org/10.47176/mjiri.35.19

Ejemplares similares

Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study
por: Makhzoom, Osama, et al.
Publicado: (2019)

Correlation between 25-hydroxy vitamin D levels in women and in vitro fertilization outcomes: A cross-sectional study
por: Faisal, Raghad, et al.
Publicado: (2022)

Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acids
por: Alquobaili, Faizeh, et al.
Publicado: (2010)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Non-linear Relationship Between Plasma Amyloid-β 40 Level and Cognitive Decline in a Cognitively Normal Population
por: Gao, Fan, et al.
Publicado: (2020)

High Soluble Amyloid-β(42) Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations
por: Sturchio, Andrea, et al.
Publicado: (2022)

Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease
por: Penner, Gregory, et al.
Publicado: (2021)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
por: Cheng, Yuan, et al.
Publicado: (2022)

Pre‐amyloid stage of Alzheimer's disease in cognitively normal individuals
por: Tijms, Betty M., et al.
Publicado: (2018)

Plasma β-amyloid in Alzheimer’s disease and vascular disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults
por: Yuan, Jun, et al.
Publicado: (2023)

An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
por: Liu, Ruiyuan, et al.
Publicado: (2019)

Tenascin-C is associated with cored amyloid-β plaques in Alzheimer disease and pathology burdened cognitively normal elderly
Publicado: (2016)

The Association of Plasma Amyloid-β and Cognitive Decline in Cognitively Unimpaired Population
por: Wang, Jin, et al.
Publicado: (2022)

Resilience to Plasma and Cerebrospinal Fluid Amyloid-β in Cognitively Normal Individuals: Findings From Two Cohort Studies
por: Lin, Li, et al.
Publicado: (2021)

Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease()
por: Chételat, Gaël, et al.
Publicado: (2013)

Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers
por: Tosun, Duygu, et al.
Publicado: (2021)

Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer’s Disease
por: Gentreau, Mélissa, et al.
Publicado: (2022)

Vascular Health is Associated with Amyloid-β in Cognitively Normal Older Adults
por: Liu, Yumei, et al.
Publicado: (2019)

Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
por: Pelkmans, Wiesje, et al.
Publicado: (2021)

Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
por: Pfundstein, Grant, et al.
Publicado: (2022)

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease
por: Murray, John, et al.
Publicado: (2014)

The global Alzheimer's Association round robin study on plasma amyloid β methods
por: Pannee, Josef, et al.
Publicado: (2021)

Plasma amyloid-β ratios in autosomal dominant Alzheimer’s disease: the influence of genotype
por: O'Connor, Antoinette, et al.
Publicado: (2021)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load
por: Chatterjee, Pratishtha, et al.
Publicado: (2020)

Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals
por: van der Kall, Laura M., et al.
Publicado: (2021)

Mesial temporal tau in amyloid-β-negative cognitively normal older persons
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Identifying Drug-Therapy Problems among Syrian Refugees in Zaatari Refugee Camp
por: Hammad, Alaa M., et al.
Publicado: (2022)

Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden
por: Tomadesso, Clémence, et al.
Publicado: (2022)

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
por: Ferreira, Sergio T., et al.
Publicado: (2015)

Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease
por: Lourenco, Mychael V., et al.
Publicado: (2020)

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease
por: Meng, Xue, et al.
Publicado: (2019)

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
por: Stockmann, Julia, et al.
Publicado: (2020)

Association of deposition of tau and amyloid‐β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer’s disease spectrum patients
por: Shigemoto, Yoko, et al.
Publicado: (2018)

β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis
por: Li, Tao-Ran, et al.
Publicado: (2022)

Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease
por: De Kort, Anna M., et al.
Publicado: (2021)

Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer’s Disease
por: Kobro-Flatmoen, Asgeir, et al.
Publicado: (2023)

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model
por: Cho, Soo Min, et al.
Publicado: (2014)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8v7toqtd8l41v6v1drn1bacd19